International Journal of Phytomedicine and Phytotherapy
Ref. (only placebo controlled) | Design | Patient Characteristics and Age | Treatment, Dose, and Duration | Outcome Measures | Finding and Comments | Effects in short No = Ø Signif. pos = + Signif. neg = − |
---|---|---|---|---|---|---|
Milewicz et al., 1993 [22] | Randomized, placebo controlled trial | 11 VAC extract. 11placebo treated women with PMS and latent hyperprolactinemia, mean age 30 y | 20 mg of an extract of VAC dried fruits (Strotan) for 3 months | PMS. Basal and TRHstimulated prolactin, lutael phase progesterone | Reduction of PMS in 9 verum but only in 2 placebo treated women | + |
Turner et al., 1993 [21] | Randomized, double blind placebocontrolled trial | 600 verum, 217 soy based placebo. age 18–46 y | 3×600 mg/day of a not defined VAC extract, 3 months | Moos Menstrual Distress Questionnaire | No significant effects on all but one item placebo effects better than verum, note however, the extremely high dose | Ø |
Lauritzen et al., 1997 [23] | Randomized, double blind. comparatorsudy | 46 VAC. 57 pyridoxine treated women with PMS, 18–45 y | 3.5–4.2 mg dried VAC extract (Agnolyt) vs pyridoxine, 3 cycles | PMS was measured by VAS premenstrual Tension Scale | Significant “excellent” reduction of PMS superior to pyridoxine | + |
Schellenberg et al., 2001 [26] | Randomized, double-blind, placebocontrolled | 170 women with PMS Mean age 36 y | 86 VAC, 84 placebo treated women with PMS, 3 cycles | 20 mg of a VAC extract Ze 440, | Significant reduction of all symptoms in comparison to placebo (except bloating) | + |
Wuttke et al. 1997 [24] | Randomized, double-blind, placebocontrolled | 104 patients with premenstrual mastodynia determined by VAS | 66 patients treated with 40 mg dried fruit VAC, 38 placebo, 3 cycles | Visual analogue score of mastodynia | Significantly better improvement of mastodynia under both VAC peparations | + |
Halaska et al. 1999 [25] | Randomized, double-blind, placebo controlled | 97 patients with premenstrual mastodynia determined by VAS | 48 patients with dried VAC fruit, 49 with placebo, 3 cycles | Visual analogue score of mastodynia | Significantly better reduction of mastodynia under VAC | + |
He at al., 2009 [29] | Randomized, double-blind, placebocontrolled trial | 101 women verum vs 101 placebo for 3 cycles | 40 mg dried fruit powder (equivalent to 4 mg dried extract vs placebo | Moderate to severe forms of PMS assessed by DSM IV and PMTS score greater than 18 | Significantly greater improvement under VAC (80%) than under placebo (50%) | + |
Ma et al., 2010 [31] | Randomized, double blind, placebo controlled trial | 31 women with verum vs 33 women under placebo, 3 cycles | 40 mg dried fruit powder vs placebo given during luteal phase | PMSD score greater 16 points | Significantly greater improvement under VAC (85%) vs placebo (56%) | + |
Kilicdag et al., 2004 [27] | Randomized, double blind comparator controlled trial | 40 women with mastodynia and 40 women with latent hyperprolactinemia | 2×40 mg dried fruit vs 2×2.5 bromocriptine daily for 3 months | Breast discomfort by VAS | Both treatments were similarly effective Fewer side effects under VAC | + |
Gumenyuk (2010) [45] | Randomized oprn 3 months | 31 with PMS 19 of them PMDy | 40 mg VAC(Mastodynon) | PMS, mastodynia, prolactin | Significant reduction of all parameters | + |
Pakgohar et al., 2009 [30] | Randomized, double-blind, placebocontrolled, | 39 women with verum, 50 with placebo | 4.3–4.8 mg dried VAC extract vs placebo | PMS diagnosed by general practitioner | Improvement significantly better under VAC (61%) vs placebo (29%) | + |
Ciotta et al., 2011 [33] | Randomized, double blind, comparator controlled | 31 women under verum vs 26 under fluoxetine, 2 months | 20 mg dried fruit powder vs 20–40 mg fluoxetine | DSM IV criteria for severe PMS | Both treatments improved symptoms significantly with better outcome for fluoxetine | + |
Zamani et al., 2012 [34] | Randomized, double-blind, placebocontrolled trial | 62 verum vs 66 women under placebo for 6 days prior to expected menstrual bleeding for 6 cycles | 40 drops of an undefined VAC extract vs placebo | Selection by DSM IV criteria i | Significantly better effects for all items under VAC in comparison to placebo | + |
Schellenberg et al. 2012 [35] | Randomized, double-blind, placebo controlled, | 4 groups of women (3 verum. Vs placebo) with PMS, 18–45 y | 8, 20 and 30 mg drie VAC fruit vs plavebo40 mg VAC dried fruit (Mastodynon) vs placebo | Premensrual mastodynia i | Dose dependent significant reduction of mastodynia | + |
Malykhina 2006 [28] | Randomized single-blind, comparator controlled | 120 women with mastalgia and latent hyper-prolactinemia divided in 3 groups | 2.5 mg bromocriptine, 0.25 mg Dostinex, 40 mg dried fruit VAC (Agnucaston) all given for 3 months | Mastalgia and latent hyperprolactinemia | Breast pain absent within 2 weeks in all 3 groups. Normalization of prolactin at the end of the study in all 3 groups | + |
Suturina and Popova, 2010 [32] | Randomized, single-blind, comparator controlled | 2 goups of women (24 in each group) after intensive gynecologic check up | 40 mg of dried VAC fruit (Cyclodynon) vs 2.5 mg bromocripitine, twice daily for 3 months | Questionnaire and serum prolactin | Significant reduction of mastalgia in both groups, Cyclodynon improved symptoms in all bromocriptine only in 16 patients, | + |
Tuganbekov and Oralbay 2012 [46] | Non randomized, prospective study, 2 monnths | 30 women with fibrocystic mastopathy with mastodynia | 40 mg VAC dried fruit (Mastodynon) | Changes in fibrocystic appearance, serum prolactin, TSH and estradiol | Significant (90%) reduction of fibrocystic appearance, mastodynia and prolactin | + |
Ledina and Prelipskaya 2011 [36] | Randomized. 2 months | 50 women with mastalgia | 1 group (n = 30) with VAC, the other with an COC (n = ` 20) | Visual analogue scale | Significant effects of both treatments VAC > than COC | + |
v Kubista et al. 1986 | Randomized, double-blind trial vs placebo and a progestin | 38 verum vs 28 progestin vs 55 placebo | VAC 1095 (Mastodynon) vs a progestin vs placebo | Mastodynia, often in combination with fibrocystic mastopathy | Reduction under progestin 89%, under VAC 74% and under placebo 37% | + |